Microanalyses of beta-cyclodextrin in plasma by high-performance liquid chromatography

Area of Science:

• Analytical Chemistry
• Pharmacokinetics
• Biochemistry

Background:

• Accurate quantification of beta-cyclodextrin (beta-CyD) in biological matrices like plasma is crucial for pharmacokinetic studies.
• Existing methods may lack the sensitivity, efficiency, or ease of sample preparation required for micro-determination.

Purpose of the Study:

• To investigate and compare four distinct high-performance liquid chromatography (HPLC) methods for the micro-determination of beta-cyclodextrin in plasma.
• To identify the most suitable method for routine analysis and pharmacokinetic investigations.

Main Methods:

• Four HPLC methods were evaluated: direct detection of underivatized beta-CyD using refractive index detection (Methods A & B) with different stationary phases, derivatization followed by UV detection (Method C), and radiolabeling with liquid scintillation counting (Method D).
• Plasma proteins were removed using centrifugal ultrafiltration (MPS-1 system).
• Method B utilized a C18-bonded silica column with a methanol-water mobile phase for direct beta-CyD detection.

Main Results:

• Method B demonstrated superior performance compared to Methods A, C, and D in terms of sample preparation simplicity, analytical sensitivity, and time efficiency.
• Method B was successfully applied to determine the cumulative absorption of beta-cyclodextrin in rat mesenteric vein plasma following administration of a phenobarbital-beta-cyclodextrin complex.

Conclusions:

• High-performance liquid chromatography (HPLC) offers viable options for beta-cyclodextrin (beta-CyD) quantification in plasma.
• Method B, employing a C18 column and refractive index detection, is recommended as the preferred method due to its practical advantages for analyzing beta-cyclodextrin pharmacokinetics.